Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session

Published 06/09/2022, 18:36
Updated 06/09/2022, 19:10
© Reuters.  Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session

Gainers

  • HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
  • ChannelAdvisor Corporation (NYSE: ECOM) shares climbed 54.9% to $22.77 after the company announced it will be acquired by CommerceHub for $23.10 per share
  • IVERIC bio, Inc. (NASDAQ: ISEE) gained 41.4% to $13.35 after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA).
  • Nutex Health, Inc. (NASDAQ: NUTX) rose 39% to $3.33. Nutex Health recently reported Q2 earnings results.
  • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) rose 37.4% to $20.47 amid post-IPO volatility.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) shares climbed 34.1% to $4.2650 after gaining 7% on Friday.
  • Spero Therapeutics, Inc. (NASDAQ: SPRO) surged 30% to $0.9472. Spero Therapeutics received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection (cUTI).
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) jumped 20% to $1.11 after climbing over 23% on Friday.
  • Kaspien Holdings Inc. (NASDAQ: KSPN) rose 18.7% to $2.92.
  • CytomX Therapeutics, Inc. (NASDAQ: CTMX) gained 18.5% to $1.73. CytomX Therapeutics, last month, posted a Q2 loss of $0.37 per share.
  • SelectQuote, Inc. (NYSE: SLQT) jumped 17.3% to $1.1150. SelectQuote recently said Q4 sales results were lower year-over-year and issued FY23 sales guidance below analyst estimates.
  • Pear Therapeutics, Inc. (NASDAQ: PEAR) rose 16% to $2.47. Pear Therapeutics, last month, posted Q2 EPS of $0.04.
  • LifeStance Health Group, Inc. (NASDAQ: LFST) gained 16% to $7.93.
  • Apexigen, Inc. (NASDAQ: APGN) gained 15.9% to $6.06.
  • Regulus Therapeutics Inc. (NASDAQ: RGLS) jumped 15.4% to $1.6383. Regulus Therapeutics, last month, posted a Q2 loss of $0.50 per share.
  • American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT (LON:AVCT)) gained 15% to $0.2428. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
  • Akumin Inc. (NASDAQ: AKU) gained 13.4% to $1.35. Akumin recently received notification letter from the Nasdaq confirming that company had regained compliance with minimum bid price requirement.
  • Dakota Gold Corp. (NYSE: DC) jumped 12.9% to $3.49.
  • ADT Inc. (NYSE: ADT) gained 12.4% to $8.10 after the company announced it has secured investments totaling $1.5 billion from State Farm and Google (NASDAQ:GOOGL).
  • SES AI Corporation (NYSE: SES) jumped 12% to $5.24.
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 10.7% to $0.3544 after gaining around 5% on Friday.
  • TScan Therapeutics, Inc. (NASDAQ: TCRX) rose 10.4% to $3.61.
  • Organovo Holdings, Inc. (NASDAQ: ONVO) gained 10% to $2.54.
  • Nordic American Tankers Limited (NYSE: NAT) rose 9.8% to $2.8550. Jefferies upgraded Nordic American Tankers from Hold to Buy and raised the price target from $3 to $4.
  • Zeta Global Holdings Corp. (NYSE: ZETA) jumped 9.4% to $6.99.
  • Outfront Media Inc. (NYSE: OUT) rose 7.7% to $18.60 after it was announced the company is set to join the S&P SmallCap 600.
  • Belite Bio, Inc (NASDAQ: BLTE) gained 7.2% to $37.40.
Don’t forget to check out our premarket coverage here .

Losers

  • ProKidney Corp. (NASDAQ: PROK) shares tumbled 31.3% to $7.01. ProKidney recently named Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations.
  • Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) dropped 27.4% to $0.0760 after the company announced it has filed for bankruptcy.
  • Creatd, Inc. (NASDAQ: CRTD) shares fell 26.4% to $0.2766 after dipping 31% on Friday. Creatd received delist decision and received 15 days to file appeal.
  • ZeroFox Holdings, Inc. (NASDAQ: ZFOX) dropped 26.2% to $3.8477.
  • Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) shares fell 25.8% to $6.34 after the company provided an update on the status of its planned request for EUA of peginterferon lambda, saying "the agency has indicated that it is not yet able to determine whether the criteria for the submission of an application and issuance of an EUA are likely to be met."
  • Presidio Property Trust, Inc. (NASDAQ: SQFT) fell 25.3% to $2.35. Presidio Property Trust declared Q3 dividend and adopted variable dividend policy.
  • Hempacco Co., Inc. (NASDAQ: HPCO) dipped 23.3% to $4.3250.
  • POINT Biopharma Global Inc. (NASDAQ: PNT) fell 20.9% to $8.10.
  • bioAffinity Technologies, Inc. (NASDAQ: BIAF) fell 20.8% to $5.58 after dropping 15% on Friday. The company, last week, priced its IPO at $6.125 per unit.
  • Digital World Acquisition Corp (NASDAQ: DWAC) shares fell 19.2% to $20.20. Shareholders have rejected the special purpose acquisition company’s proposal to extend by a year the deadline for its merger with former President Donald Trump’s Trump Media & Technology, which operates the Truth Social platform, Reuters reported.
  • Rigetti Computing, Inc. (NASDAQ: RGTI) dropped 19% to $2.9488.
  • Kingsoft Cloud Holdings Limited (NASDAQ: KC) declined 18.3% to $2.4650 following downbeat quarterly sales.
  • Addentax Group Corp. (NASDAQ: ATXG) shares fell 18% to $7.78 following the company's uplisting and IPO.
  • Sera Prognostics, Inc. (NASDAQ: SERA) fell 17% to $1.6450. Sera Prognostics, last month, posted a Q2 loss of $0.37 per share.
  • ShiftPixy, Inc. (NASDAQ: PIXY) dropped 16.9% to $11.30.
  • Nuwellis, Inc. (NASDAQ: NUWE) dipped 16.3% to $1.03.
  • Tupperware Brands Corporation (NYSE: TUP) declined 16.3% to $9.22.
  • Glatfelter Corporation (NYSE: GLT) fell 15.8% to $4.1550. Glatfelter recently named Mr. Thomas Fahnemann as President and Chief Executive Officer.
  • CalAmp Corp. (NASDAQ: CAMP) dropped 15.5% to $4.6050.
  • PaxMedica, Inc. (NASDAQ: PXMD) fell 15.2% to $4.3863 following the company's recent IPO.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 14.7% to $7.36 following the passing of CFO Gustavo Arnal. Raymond James recently downgraded the stock form Market Perform to Underperform.
  • eHealth, Inc. (NASDAQ: EHTH) dropped 14.3% to $4.8450.
  • Cheetah Mobile Inc. (NYSE: CMCM) fell 14.3% to $3.17.
  • ASAP, Inc. (NASDAQ: WTRH) fell 14.2% to $0.1980.
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) dropped 14% to $9.95.
  • Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) fell 13.2% to $2.30 after climbing around 27% on Friday.
  • Burcon NutraScience Corporation (NASDAQ: BRCN) fell 12.7% to $0.4542 as the company reported delisting from Nasdaq Capital Market on or about September 12. The company also announced auditor resignation and postponement of annual meeting of shareholders.
  • Tango Therapeutics, Inc. (NASDAQ: TNGX) fell 12.6% to $3.74.
  • Getty Images Holdings, Inc. (NYSE: GETY) dropped 12.2% to $13.05.
  • Kuke Music Holding Limited (NYSE: KUKE) fell 12.1% to $0.7210 after dipping 27% on Friday.
  • Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) fell 11.5% to $4.71.
  • MoonLake Immunotherapeutics (NASDAQ: MLTX) dipped 11.1% to $7.66.
  • Hillenbrand, Inc. (NYSE: HI) dropped 8.5% to $37.12. The company, last month, posted upbeat quarterly results.
  • ADTRAN Holdings, Inc. (NASDAQ: ADTN) fell 8.4% to $20.73.
  • HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) fell 7.3% to $4.44. HIVE reported its August 2022 production figures and mining capacity.
  • GameStop Corp . (NYSE: NYSE:GME) fell 7.2 to $25.40.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.